Disclosed are methods and intermediates for the preparation of 7-(2'-R.sup.1-substituted-.beta.-D-ribofuranosyl)-4-amino-5-(optionally substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine compounds. These compounds are useful in treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus.

 
Web www.patentalert.com

< Design and therapeutic use of adpase enhanced apyrases

< Modulation of tyrosinase expression

> Nucleoside compounds for treating viral infections

> 4' -C-substituted-2-haloadenosine derivative

~ 00211